Alprazolam may increase the sedative activities of Ropinirole. The metabolism of Lomustine can be decreased when combined with Ropinirole. Magnesium Sulfate may increase the sedative activities of Ropinirole. Gabapentin Enacarbil may increase the sedative activities of Ropinirole. Canertinib may increase the sedative activities of Ropinirole. The metabolism of Ixazomib can be decreased when combined with Ropinirole. Fluvoxamine may increase the sedative activities of Ropinirole. Glutethimide may increase the sedative activities of Ropinirole. Barbexaclone may increase the hypotensive activities of Ropinirole. The metabolism of Nicardipine can be decreased when combined with Ropinirole. Cetirizine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Dinutuximab. Fencamfamine may increase the sedative activities of Ropinirole. Triazolam may increase the sedative activities of Ropinirole. Fludiazepam may increase the sedative activities of Ropinirole. Clidinium may increase the sedative activities of Ropinirole. Fentanyl may increase the sedative activities of Ropinirole. The metabolism of Pentamidine can be decreased when combined with Ropinirole. The metabolism of Granisetron can be decreased when combined with Ropinirole. The serum concentration of Ropinirole can be decreased when it is combined with St. John's Wort. The metabolism of Ropinirole can be decreased when combined with Pargyline. The metabolism of Ropinirole can be decreased when combined with Itraconazole. The metabolism of Praziquantel can be decreased when combined with Ropinirole. Paliperidone may increase the sedative activities of Ropinirole. Tetrahydropalmatine may increase the sedative activities of Ropinirole. The metabolism of Etoricoxib can be decreased when combined with Ropinirole. Allopregnanolone may increase the sedative activities of Ropinirole. The metabolism of Debrisoquin can be decreased when combined with Ropinirole. Zuclopenthixol may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Sacubitril. The metabolism of Dexfenfluramine can be decreased when combined with Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Luliconazole. Cinchocaine may increase the sedative activities of Ropinirole. The metabolism of Halofantrine can be decreased when combined with Ropinirole. The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Ropinirole. Remoxipride may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Spironolactone. Ondansetron may increase the sedative activities of Ropinirole. Sevoflurane may increase the sedative activities of Ropinirole. The therapeutic efficacy of Ropinirole can be decreased when used in combination with Cariprazine. Thiothixene may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Methylene blue. Ziprasidone may increase the sedative activities of Ropinirole. The metabolism of Sertraline can be decreased when combined with Ropinirole. The metabolism of Flutamide can be decreased when combined with Ropinirole. Eltanolone may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Telaprevir. The serum concentration of Ropinirole can be decreased when it is combined with Enzalutamide. Hydromorphone may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Fusidic Acid. Gamma Hydroxybutyric Acid may increase the sedative activities of Ropinirole. Adipiplon may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Genistein. Trifluoperazine may increase the sedative activities of Ropinirole. Ziconotide may increase the sedative activities of Ropinirole. Brotizolam may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Methazolamide. Ropinirole may increase the atrioventricular blocking (AV block) activities of Carvedilol. Iloperidone may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Iloprost is combined with Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Chlorothiazide. Tranylcypromine may increase the sedative activities of Ropinirole. Tapentadol may increase the sedative activities of Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Platelet Activating Factor. Clorazepate may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Phentolamine is combined with Ropinirole. The metabolism of Ropinirole can be decreased when combined with Sulfisoxazole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Moexipril. Ropinirole may increase the atrioventricular blocking (AV block) activities of Bevantolol. The serum concentration of Ropinirole can be increased when it is combined with Netupitant. Perospirone may increase the sedative activities of Ropinirole. Alphaprodine may increase the sedative activities of Ropinirole. The metabolism of Theobromine can be decreased when combined with Ropinirole. The metabolism of Galantamine can be decreased when combined with Ropinirole. Fexofenadine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Eprosartan. Methylphenobarbital may increase the sedative activities of Ropinirole. The metabolism of Eletriptan can be decreased when combined with Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Fosaprepitant. The metabolism of Rotigotine can be decreased when combined with Ropinirole. Etomidate may increase the sedative activities of Ropinirole. Promazine may increase the sedative activities of Ropinirole. Tetrabenazine may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Ropinirole is combined with Quinapril. Ropinirole may increase the atrioventricular blocking (AV block) activities of Indenolol. Amperozide may increase the sedative activities of Ropinirole. The metabolism of Diclofenac can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Ropinirole. Ropivacaine may increase the sedative activities of Ropinirole. The metabolism of Levomilnacipran can be decreased when combined with Ropinirole. Flurazepam may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Streptokinase. Norflurane may increase the sedative activities of Ropinirole. The metabolism of Rofecoxib can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Pramipexole is combined with Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Penbutolol. The metabolism of Cevimeline can be decreased when combined with Ropinirole. Zotepine may increase the sedative activities of Ropinirole. Dextropropoxyphene may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Cobicistat. The risk or severity of adverse effects can be increased when Nilvadipine is combined with Ropinirole. The therapeutic efficacy of Ropinirole can be decreased when used in combination with Sarilumab. Lithium may increase the sedative activities of Ropinirole. The metabolism of Pyrazinamide can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Amlodipine. Dexbrompheniramine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Isosorbide Mononitrate. The risk or severity of adverse effects can be increased when Ropinirole is combined with Levobunolol. Ethyl carbamate may increase the sedative activities of Ropinirole. Clomipramine may increase the sedative activities of Ropinirole. Paraldehyde may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Estrone. Flunitrazepam may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Candesartan cilexetil. Methotrimeprazine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Mecamylamine. Opipramol may decrease the antihypertensive activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Quinestrol. The risk or severity of adverse effects can be increased when Ropinirole is combined with Canagliflozin. The risk or severity of adverse effects can be increased when Ropinirole is combined with Selegiline. Lormetazepam may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Ethinyl Estradiol. The metabolism of Ropinirole can be decreased when combined with Darunavir. Amobarbital may increase the sedative activities of Ropinirole. Heroin may increase the sedative activities of Ropinirole. The metabolism of Nateglinide can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydralazine. The risk or severity of adverse effects can be increased when Ropinirole is combined with Azilsartan medoxomil. Chlormezanone may increase the sedative activities of Ropinirole.